Filament Health Corp Stock Investor Sentiment

FLHLF Stock  USD 0.03  0.01  14.29%   
Roughly 62% of Filament Health's investor base is looking to short. The analysis of current outlook of investing in Filament Health Corp suggests that many traders are alarmed regarding Filament Health's prospects. The current market sentiment, together with Filament Health's historical and current headlines, can help investors time the market. In addition, many technical investors use Filament Health Corp stock news signals to limit their universe of possible portfolio assets.
Filament Health otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Filament daily returns and investor perception about the current price of Filament Health Corp as well as its diversification or hedging effects on your existing portfolios.
  
over three months ago at news.google.com         
FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING LED BY ... - Psychedeli...
Google News at Macroaxis
over six months ago at news.google.com         
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS - The Globe and Mail
Google News at Macroaxis
over six months ago at news.google.com         
Filament Health Expands Global Psychedelic Drug Trials - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS - Yahoo Ca...
Google News at Macroaxis
over six months ago at news.google.com         
FILAMENT HEALTH TO DISCUSS ITS DRUG DEVELOPMENT PLATFORM IN FIRESIDE CHAT WITH WATER TOWER ... - The...
Google News at Macroaxis
over six months ago at news.google.com         
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders - Yaho...
Google News at Macroaxis
over six months ago at news.google.com         
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaqs Bid Price R...
Google News at Macroaxis
over six months ago at news.google.com         
Filament Health Advances Psychedelic Drug PEX010 - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
FILAMENT HEALTH REPORTS Q4 AND YEAR END 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS - Marketsc...
Google News at Macroaxis
over six months ago at news.google.com         
Filament Health Corp. Announces Chief Financial Officer Changes - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
FILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL ... - Mar...
Google News at Macroaxis
over six months ago at news.google.com         
Jaguar Health to appeal potential Nasdaq delisting By Investing.com - Investing.com Australia
Google News at Macroaxis
over six months ago at news.google.com         
Filament Health Corp at OTC Markets KCSA Mental Health Investor Conference Transcript - GuruFocus.co...
Google News at Macroaxis
over six months ago at news.google.com         
Filament Health Completes the First Export of Biological Psilocybin to Australia - Marketscreener.co...
Google News at Macroaxis
over six months ago at news.google.com         
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS - Marketscreener.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Filament Health that are available to investors today. That information is available publicly through Filament media outlets and privately through word of mouth or via Filament internal channels. However, regardless of the origin, that massive amount of Filament data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Filament Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Filament Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Filament Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Filament Health alpha.

Filament Health Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Filament OTC Stock analysis

When running Filament Health's price analysis, check to measure Filament Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Filament Health is operating at the current time. Most of Filament Health's value examination focuses on studying past and present price action to predict the probability of Filament Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Filament Health's price. Additionally, you may evaluate how the addition of Filament Health to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios